Flexibility of Na,K-ATPase secondary structure upon drug-protein interaction

The enzyme Na⁺, K⁺-ATPase is an integral membrane protein which transports sodium and potassium cations against an electrochemical gradient. The transport of Na⁺ and K⁺ ions is connected to an oscillation of the enzyme between the two conformational states, the E₁ (Na⁺) and the E₂ (K⁺) conformations. The enzymatic activity of ATPase is largley affected by different ligands complexation. This review reports the effects of several drugs such as AZT (anti-AIDS), cis-Pt (antitumor), aspirin (anti-inflammatory) and vitamin C (antioxidant) on the stability and secondary structure of Na,K-ATPase in vitro. Drug-enzyme binding is mainly through H-bonding to the polypeptide C=O and C-N groups with two binding constants K_1(AZT) = 5.30 × 10⁵ M^?1 and K_2(AZT) = 9.80 × 10³ M^?1 for AZT and one binding constant for K_cis-Pt = 1.93 × 10⁴ M^?1, K_aspirin = 6.45 × 10³ M^?1 and K_ascorbate = 1.04 × 10⁴ M^?1 for cis-Pt, aspirin and ascorbic acid. The enzyme secondary structure was altered from that of α-helix 19.8% (free protein) to almost 22–26% and the β-sheet from 25.6% to 18–22%, upon drug complexation with the order of induced stability AZT > cis-Pt > ascorbate > aspirin.     

Methylamine interaction with proteins of photosystem II: A comparison with biogenic polyamines

Biogenic polyamines are essential for cell growth and differentiation. The interaction of polyamines with protein of photosystem II (PSII) are well investigated, while there has been no report on the effect of monoamines complexation on photosynthetic oxygen evolution. This study was designed to investigate the interaction of methylamine with proteins of PSII, using PSII-enriched submembrane fractions with various concentrations of methylamine. Fourier transformed infrared (FTIR) and fluorescence spectroscopic methods were used in order to determine the methylamine binding mode, the protein conformational changes, and the effect of amine interaction on photosynthetic oxygen evolution. Spectroscopic evidence showed that methylamine interacts with protein (H-bonding) through polypeptide CO, C–N and NH groups with major perturbations of protein secondary structure. Major reduction of α-helix from 50% (free PSII) to 35% with an increase of β-sheet from 10% (free PSII) to 16% was observed in methylamine-PSII complexes. At very low methylamine concentration, no inhibition of oxygen-evolution occurred, while at higher amine content (12 mM), 100% inhibition was observed. Chlorophyll (Chl) fluorescence measurements indicated the inhibition mainly affects the oxygen evolving complex (OEC) of PSII. Comparisons of the effects of methylamine with biogenic polyamine spermine, spermidine and putrescine showed a similar mode of binding with protein (H-bonding) through polypeptide CO, C–N and NH groups. However, major alterations of the protein secondary structure are induced by monoamine and not by polyamines.     

Interaction of zanamivir with DNA and RNA: Models for drug–DNA and drug–RNA bindings

Zanamivir (ZAN) is the first of a new generation of influenza virus-specific drugs known as neuraminidase inhibitors, which acts by interfering with life cycles of influenza viruses A and B. It prevents the virus spreading infection to other cells by blocking the neuraminidase enzyme present on the surface of the virus. The aim of this study was to examine the stability and structural features of calf thymus DNA and yeast RNA complexes with zanamivir in aqueous solution, using constant DNA or RNA concentration (12.5 mM) and various zanamivir/polynucleotide (P) ratios of 1/20, 1/10, 1/4, and 1/2. FTIR and UV–visible spectroscopy are used to determine the drug external binding modes, the binding constant and the stability of zanamivir–DNA and RNA complexes in aqueous solution. Structural analysis showed major interaction of zanamivir with G-C (major groove) and A-T (minor groove) base pairs and minor perturbations of the backbone PO₂ group with overall binding constants of K_{zanamivir–DNA} = 1.30 × 10⁴ M⁻¹ and K_{zanamivir–RNA} = 1.38 × 10⁴ M⁻¹. The drug interaction induces a partial B to A-DNA transition, while RNA remains in A-conformation.     

An overview of protein-DNA and protein-RNA interactions

In this review the fundamental question of how does protein-DNA or protein-RNA interactions affect the structures and dynamics of DNA, RNA, and protein is addressed. Two models of human serum albumin (HSA) bindings to calf-thymus DNA and transfer RNA (tRNA) are presented here. In these models the binding sites, stability and structural aspects of DNA-protein and RNA-protein are discussed. Electrostatic binding of DNA or RNA via backbone phosphate group to the positively charged amino acids on the surface of protein is prevailing. Two binding sites with K₁ = 4.8 × 10⁵ M^?1 and K₂ = 6.1 × 10⁴ M^?1 for protein-DNA and one binding affinity with K = 1.45 × 10⁴ M^?1 for protein-RNA are observed. A partial B to A-DNA transition is observed for protein-DNA complexes, while tRNA remains in A-family structure upon protein interaction.     

Complexes of zinc,cadmium and mercury(II) with the zwitter-ionic form of NN′-ethylenebis (salicylideneimine)

The Schiff base NN′-ethylenebis(salicylideneimine), H₂ salen reacts with hydrous and anhydrous Zinc, Cadmium and Mercury(II) salts to give complexes M(H₂ salen)X₂·nH₂O (M = Zn, Cd, Hg; XCl, Br, I, NO₃; MZn, X₂SO₄; n = 0?2). Spectroscopic and other evidence indicated that; (i) halide and sulphate are coordinated to the metal ion, whereas the nitrate group is ionic in mercury nitrate compound and covalently bonded in zinc and cadmium nitrato complexes, (ii) the Schiff base is coordinated through the negatively charged phenolic oxygen atoms and not the nitrogen atoms, which carry the protons transferred from phenolic groups on coordination, (iii) therefore the coordination numbers suggested are 4-, in mercury and 4- or 6- in zinc and cadmium Schiff base complexes.     

Conformational analysis of Na,K-ATPase in drug-protein complexes

This review reports the effects of several drugs such as AZT (anti-AIDS), cis-Pt (antitumor), aspirin (anti-inflammatory) and vitamin C (antioxidant) on the stability and conformation of Na,K-ATPase in vitro. Drug-enzyme binding was found to be via H-bonding to the polypeptide CO and C-N groups with two binding constants K(1(AZT))=5.30 (+/-2.1)x10(5)M(-1) and K(2(AZT))=9.80 (+/-2.9)x10(3)M(-1) for AZT and one binding constant K(cis)(-Pt)=1.93 (+/-1.2)x10(4)M(-1) for cis-Pt, K(aspirin)=6.45 (+/-2.5)x10(3)M(-1) and K(ascorbate)=1.04 (+/-0.5)x10(4)M(-1) for aspirin and ascorbic acid. The enzyme secondary structure was altered with major increase of alpha-helix from 19.9% (free protein) to 22-26% and reduction of beta-sheet from 25.6% (free protein) to 17-23% upon drug complexation indicating a partial stabilization of protein conformation. The order of induced stability is AZT>cis-Pt>ascorbate>aspirin.     

RNA binding to antioxidant flavonoids

Flavonoids are an interesting group of natural polyphenolic compounds that exhibit extensive bioactivities such as scavenging free radical, antitumor and antiproliferative effects. The anticancer and antiviral effects of these natural products are attributed to their potential biomedical applications. While flavonoids complexation with DNA is known, their bindings to RNA are not fully investigated. This study was designed to examine the interactions of three flavonoids; morin (Mor), apigenin (Api) and naringin (Nar) with yeast RNA in aqueous solution at physiological conditions, using constant RNA concentration (6.25 mM) and various pigment/RNA (phosphate) ratios of 1/120 to 1/1. FTIR, UV-visible spectroscopic methods were used to determine the ligand binding modes, the binding constant and the stability of RNA in flavonoid-RNA complexes in aqueous solution. Spectroscopic evidence showed major binding of flavonoids to RNA with overall binding constants of K(morin) = 9.150 x 10(3) M(-1), K(apigenin)=4.967 x 10(4) M(-1), and K(naringin)=1.144 x 10(4) M(-1). The affinity of flavonoid-RNA binding is in the order of apigenin>naringin>morin. No biopolymer secondary structural changes were observed upon flavonoid interaction and RNA remains in the A-family structure in these pigment complexes.     

Interaction of antitumor drug Sn(CH3)2Cl2 with DNA and RNA

Sn(CH₃)₂Cl₂ exerts its antitumor activity in a specific way. Unlike anticancer cis-Pt(NH₃)₂Cl₂ drug which binds strongly to the nitrogen atoms of DNA bases, Sn(CH₃)₂Cl₂ shows no major affinity towards base binding. Thus, the mechanism of action by which tinorganometallic compounds exert antitumor activity would be different from that of the cisplatin drug. The aim of this study was to examine the binding of Sn(CH₃)₂Cl₂ with calf thymus DNA and yeast RNA in aqueous solutions at pH 7.1–6.6 with constant concentrations of DNA and RNA and various molar ratios of Sn(CH₃)₂Cl₂/DNA (phosphate) and Sn(CH₃)₂Cl₂/RNA of 1/40, 1/20, 1/10, 1/5. Fourier transform infrared (FTIR) and UV–visible difference spectroscopic methods were used to determine the Sn(CH₃)₂Cl₂ binding mode, binding constant, sequence selectivity and structural variations of Sn(CH₃)₂Cl₂/DNA and Sn(CH₃)₂Cl₂/RNA complexes in aqueous solution. Sn(CH₃)₂Cl₂ hydrolyzes in water to give Sn(CH₃)₂(OH)₂ and [Sn(CH₃)₂(OH)(H₂O)_n]⁺ species. Spectroscopic evidence showed that interaction occurred mainly through (CH₃)₂Sn(IV) hydroxide and polynucleotide backbone phosphate group with overall binding constant of K(Sn(CH₃)₂Cl₂–DNA)=1.47×10⁵ M⁻¹ and K(Sn(CH₃)₂Cl₂–RNA)=7.33×10⁵ M⁻¹. Sn(CH₃)₂Cl₂ induced no biopolymer conformational changes with DNA remaining in the B-family structure and RNA in A-conformation upon drug complexation.     

Preparation,spectroscopic and structural analysis of uranium-arabinose complexes

The reaction betweenL-arabinose and hydrated uranyl salts has been investigated in aqueous solution and the solid complexes of the type UO₂(L-arabinose)X ₂ · 2 H₂O, whereX=Cl^–, Br^–, and NO ₃ ^– , have been isolated and characterized. Due to the marked similarities with those of the structurally known Ca(L-arabinose)X ₂ · 4 H₂O and Mg(L-arabinose)X ₂ · 4 H₂O (X=Cl^– or Br^–) compounds, the UO ₂ ²⁺ ion binds obviously to twoL-arabinose moieties, through O1, O5 of the first and O3, O4 of the second molecule resulting into a six-coordinated geometry around the uranium ion with no direct U-X (X=Cl^–, Br^– or NO ₃ ^– ) interaction. The intermolecular hydrogen bonding network of the freeL-arabinose is rearranged upon uranium interaction. The -anomer configuration is predominant in the freeL-arabinose, whereas the -anomer conformation is preferred in the uranium complexes.

---

Darstellung, spektroskopische und Strukturanalyse von Uran-Arabinose Komplexen

Zusammenfassung Es wurde die Reaktion zwischenL-Arabinose und hydratisierten Uranylsalzen in wäßriger Lösung untersucht und kristalline Komplexe des Typs UO₂(L-Arabinose)X ₂ · 2 H₂O mitX=Cl^–, Br^– und NO ₃ ^– isoliert und charakterisiert. Wie aus markanten Ähnlichkeiten der Komplexe mit den bekannten Verbindungen Ca(L-Arabinose)X ₂ · 4 H₂O und Mg(L-Arabinose)X ₂ · 4 H₂O (X=Cl^– oder Br^–) abzuleiten ist, bindet das UO ₂ ²⁺ -Ion mit zweiL-Arabinose Einheiten, wobei sich durch die O1,O5-Koordination des ersten und die O3,O4-Koordination des zweiten Moleküls eine sechs-koordinierte Geometrie um das Uranylion [ohne direkte U-X (X=Cl^–, Br^– oder NO ₃ ^– ) Wechselwirkung] ausbildet. Die intermolekularen Wasserstoffbrücken zeigen nach der Wechselwirkung mit dem Uranylion eine Umgruppierung. In der freienL-Arabinose ist das -Anomere vorherrschend, in den Urankomplexen hingegen das -Anomere.